Peng Ji-Bin, Suzuki Yoshiro, Gyimesi Gergely, Hediger Matthias A.
The epithelial calcium (Ca) channels TRPV5 and TRPV6 are members of the transient receptor potential (TRP) channel family TRPV (“V” for vanilloid) subgroup. TRPV5 and TRPV6 play major roles in the maintenance of blood Ca levels in higher organisms. Both channels exhibit similarities in many ways, as they share a high level (75%) of amino acid identity, comparable functional properties, and similar mechanisms of regulation. Also, they were discovered using similar cloning strategies [1,2]. Yet, their physiological contributions toward maintaining a systemic calcium balance are distinct. In addition, the following three key features distinguish TRPV5 and TRPV6 from other members of the TRP superfamily of cation channels: (1) high selectivity for Ca over other cations, (2) apical membrane localization in Ca-transporting epithelial tissues, and (3) responsiveness to 1,25-dihydroxyvitamin D (1,25[OH]D) [3,4]. These features make TRPV5 and TRPV6 ideally suited to facilitate intestinal absorption and renal reabsorption of Ca, serving as apical Ca entry channels in transepithelial Ca transport [5,6]. A major difference between the properties of TRPV5 and TRPV6 lies in their tissue distribution: TRPV5 is predominantly expressed in the distal convoluted tubules (DCT) and connecting tubules (CNT) of the kidney, with limited expression in extrarenal tissues [1,7]. In contrast, TRPV6 exhibits a broader expression pattern, showing prominent expression in the intestine with additional expression in the kidney [8–10], placenta, epididymis, exocrine tissues (i.e., pancreas, prostate, salivary gland, sweat gland), and a few other tissues [11–13]. Thus, while TRPV5 plays a key role in determining the level of urinary Ca excretion, the physiological roles of TRPV6 are not limited to intestinal Ca absorption. Much progress has recently been made in understanding the roles of TRPV5 and TRPV6 channels in the kidney [14], intestine [15], placenta [16], and epididymis [17]. However, their roles in other organs have as yet not been fully investigated. In this chapter, we review the current status of our knowledge of the physiological and pathological roles of TRPV5 and TRPV6 and discuss a variety of techniques that have led to a deeper understanding of these channels. We review the identification strategies of TRPV5 and TRPV6 in searches for Ca absorption channels, as well as specific techniques used to reveal their key features. These include radiotracer Ca uptake and electrophysiology procedures, structure-function studies, methods to identify regulatory interacting partners, genetically engineered animals, strategies to study the role of TRPV6 in cancers, procedures for the development of small-molecule modulators of TRPV6 and TRPV5, the evaluation of variations/mutations in humans, and 3D structural determination. For additional information about TRPV5 and TRPV6, we would like to refer the interested reader to other comprehensive review articles [3–6,18].
上皮钙(Ca)通道TRPV5和TRPV6是瞬时受体电位(TRP)通道家族TRPV(“V”代表香草酸)亚组的成员。TRPV5和TRPV6在维持高等生物的血钙水平方面发挥着主要作用。这两种通道在许多方面表现出相似性,它们具有高水平(75%)的氨基酸同一性、相当的功能特性以及相似的调节机制。此外,它们是通过相似的克隆策略发现的[1,2]。然而,它们在维持全身钙平衡方面的生理作用是不同的。此外,以下三个关键特征将TRPV5和TRPV6与阳离子通道TRP超家族的其他成员区分开来:(1)对Ca的选择性高于其他阳离子,(2)在钙转运上皮组织的顶端膜定位,以及(3)对1,25-二羟基维生素D(1,25[OH]D)的反应性[3,4]。这些特征使TRPV5和TRPV6非常适合促进肠道对Ca的吸收和肾脏对Ca的重吸收,作为跨上皮钙转运中的顶端钙进入通道[5,6]。TRPV5和TRPV6特性的一个主要区别在于它们的组织分布:TRPV5主要在肾脏的远曲小管(DCT)和连接小管(CNT)中表达,在肾外组织中的表达有限[1,7]。相比之下,TRPV6表现出更广泛的表达模式在肠道中显著表达,在肾脏[8-10]、胎盘、附睾、外分泌组织(即胰腺、前列腺、唾液腺、汗腺)以及其他一些组织中也有额外表达[11-13]。因此,虽然TRPV5在决定尿钙排泄水平方面起关键作用,但TRPV6的生理作用并不局限于肠道钙吸收。最近在理解TRPV5和TRPV6通道在肾脏[14]、肠道[15]、胎盘[16]和附睾[17]中的作用方面取得了很大进展。然而,它们在其他器官中的作用尚未得到充分研究。在本章中,我们回顾了我们对TRPV5和TRPV6的生理和病理作用的现有知识,并讨论了导致对这些通道有更深入理解的各种技术。我们回顾了在寻找钙吸收通道过程中TRPV5和TRPV6的鉴定策略,以及用于揭示其关键特征所使用的特定技术。这些技术包括放射性示踪剂钙摄取和电生理程序、结构-功能研究、鉴定调节相互作用伙伴的方法、基因工程动物、研究TRPV6在癌症中作用的策略、TRPV6和TRPV5小分子调节剂的开发程序、对人类变异/突变的评估以及三维结构测定。有关TRPV5和TRPV6的更多信息,我们希望向感兴趣的读者推荐其他综合综述文章[3-6,18]。